The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
Abstract Introduction We review the literature evaluating certolizumab in psoriasis and report our experience of treatment outcomes in a joint dermatology and rheumatology clinic. Methods Patients with concomitant psoriatic arthritis (PsA) and psoriasis who had been commenced on certolizumab were in...
Main Authors: | David Rutkowski, Hector Chinoy, Richard B. Warren |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-03-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13555-019-0290-5 |
Similar Items
-
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019-12-01) -
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis
by: Francesco Carubbi, et al.
Published: (2020-10-01) -
Certolizumab
by: Savaş Yaylı
Published: (2022-04-01) -
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
by: Pablo Coto-Segura, et al.
Published: (2023-09-01) -
Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris
by: Keiko Yamaguchi, et al.
Published: (2018-12-01)